Is Abbott Laboratories (ABT) a Buy, Sell, or Hold?
NYSE : ABT
Abbott Laboratories — Institutional Ownership
$104.58 USD
$1.52 (1.47%)
- Volume
- 9.14M
- Average Volume
- 13.4M
- Market Capitalization
- $182.16B
- P/E Ratio
- 33.63
- Dividend Yield
- 2.37%
- Price Target
- $120.00
- Year High
- $137.49
- Year Low
- $81.97
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.77
- Current Ratio
- $1.39
Institutional Ownership Summary
Institutional Ownership %
3.47%
Investors Holding
1034
change: -2133 | last: 3167
Increased Positions
426
change: -858 | last: 1284
Reduced Positions
473
change: -967 | last: 1440
New Positions
56
change: -122 | last: 178
Sold Positions
2118
change: 1747 | last: 371
Total Calls
6400
Total Puts
24400
Put-Call Ratio
3.81
change: 246.72 | last: 1.3453
Total Invested
8.12B
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-29 | Vanguard Capital Management | 130.68M | 7.50% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2025-12-03 | The Vanguard Group | 174.89M | 10.05% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 149.15M | 8.43% |
| 2022-02-01 | (1) BlackRock, Inc. | 137.16M | 7.80% |
| 2021-02-16 | 95-1411037 | 13.0 | 4.90% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 147.27M | 8.31% |
| 2021-01-29 | (1) BlackRock, Inc. | 133.43M | 7.50% |
| 2020-02-14 | Capital Research Global Investors ** | 113.69M | 6.40% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 151.78M | 8.58% |
| 2020-02-05 | (1) BlackRock, Inc. | 124.73M | 7.10% |
| 2019-02-04 | (1) BlackRock, Inc. | 121.05M | 6.90% |
| 2018-01-29 | (1) BlackRock, Inc. | 110.2M | 6.30% |
| 2017-01-19 | (1) BlackRock, Inc. | 87.86M | 6.00% |
| 2016-02-10 | (1) BlackRock, Inc. | 97.41M | 6.50% |
| 2015-02-09 | (1) BlackRock, Inc. | 90.98M | 6.00% |
| 2014-02-14 | Abbott Laboratories | 865.56K | 1.70% |
| 2014-01-28 | (1) BlackRock, Inc. | 88.82M | 5.70% |
| 2013-02-08 | Abbott Laboratories | 3.5M | 7.73% |
| 2013-02-08 | (1) BlackRock, Inc. | 86.07M | 5.45% |
| 2012-02-09 | (1) BlackRock, Inc. | 82.92M | 5.32% |
| 2011-02-10 | (1) BlackRock, Inc. | 75.59M | 4.89% |
| 2011-02-03 | (1) BlackRock, Inc. | 77.58M | 5.02% |
| 2010-12-10 | Abbott Laboratories (36-0698440) | - | 0.00% |
| 2010-04-21 | Amber Acquisition Inc. | 81.91M | 100.00% |
| 2010-04-21 | Abbott Laboratories | 81.91M | 100.00% |
| 2010-01-29 | BlackRock for purposes of Schedule 13G filings. | 91.72M | 5.93% |
| 2009-12-23 | Abbott Investments Luxembourg Sarl | 2.5M | 29.60% |
| 2009-12-23 | Scorpio Designated Corporation Ltd. | 2.5M | 29.60% |
| 2009-12-23 | Abbott Laboratories | 2.5M | 29.60% |
| 2009-01-21 | Rainforest Acquisition Inc. | 9.64M | 15.50% |
| 2009-01-21 | Abbott Laboratories | 12.09M | 19.40% |
| 2004-12-16 | Abbott Laboratories | - | 0.00% |
| 2004-06-21 | 36-0698440 | 1.21M | 2.93% |
| 2004-01-06 | Abbott Laboratories | 9.08M | 37.20% |
| 2003-10-10 | Abbott Laboratories | 1.55M | 8.10% |
| 2003-07-22 | Abbott Laboratories | 2M | 6.70% |
| 2003-02-05 | ###-##-#### | 92.77M | 5.60% |
| 2003-02-05 | ###-##-#### | 92.63M | 5.60% |
| 2003-02-05 | ###-##-#### | 92.77M | 5.60% |
| 2003-02-05 | Abbott Laboratories Stock Retirement Trust | 89.28M | 5.40% |
| 2001-07-17 | Abbott Laboratories | 1.08M | 11.30% |
| 2001-04-27 | Abbott Laboratories | 2M | 7.20% |
| 2001-02-08 | ###-##-#### | 98.19M | 6.40% |
| 2001-02-08 | ###-##-#### | 98.22M | 6.40% |
| 2001-02-08 | Abbott Laboratories Stock Retirement Trust | 95M | 6.10% |
| 2001-02-08 | ###-##-#### | 98.75M | 6.40% |
| 2000-06-27 | Abbott Laboratories | 537.84K | 4.02% |
| 1999-06-25 | Abbott Laboratories | 843.8K | 8.90% |
ABT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $125.29 | 1.75B | $218.88B | $8.52B | $15.07B | $225.43B |
| 2024-12-31 | $113.11 | 1.73B | $195.87B | $7.62B | $15.28B | $203.53B |
| 2023-12-31 | $110.07 | 1.73B | $190.87B | $6.9B | $15.87B | $199.85B |
| 2022-12-31 | $109.79 | 1.75B | $192.46B | $9.88B | $17.95B | $200.53B |
| 2021-12-31 | $140.74 | 1.78B | $249.81B | $9.8B | $19.25B | $259.27B |
| 2020-12-31 | $109.49 | 1.77B | $194.13B | $6.84B | $19.89B | $207.18B |
| 2019-12-31 | $86.86 | 1.77B | $153.57B | $3.86B | $19.1B | $168.81B |
| 2018-12-31 | $72.33 | 1.76B | $126.98B | $3.84B | $19.57B | $142.71B |
| 2017-12-31 | $57.07 | 1.74B | $99.51B | $9.41B | $27.92B | $118.02B |
| 2016-12-31 | $38.41 | 1.47B | $56.57B | $18.62B | $22.01B | $59.96B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90.74 | 1.74B | $158.16B | -$ | -$ | $158.16B |
| 2026-03-31 | $102.67 | 1.75B | $179.36B | $6.8B | $34.05B | $206.6B |
| 2025-12-31 | $125.29 | 1.75B | $218.88B | $8.52B | $15.07B | $225.43B |
| 2025-09-30 | $133.94 | 1.75B | $234.26B | $7.51B | $12.94B | $239.69B |
| 2025-06-30 | $136.01 | 1.74B | $236.72B | $6.95B | $13.44B | $243.21B |
| 2025-03-31 | $132.65 | 1.75B | $231.77B | $6.53B | $13.24B | $238.48B |
| 2024-12-31 | $113.11 | 1.73B | $195.87B | $7.62B | $15.28B | $203.53B |
| 2024-09-30 | $114.01 | 1.73B | $197.75B | $7.56B | $14.98B | $205.17B |
| 2024-06-30 | $103.20 | 1.73B | $178.96B | $6.99B | $14.75B | $186.72B |
| 2024-03-31 | $112.09 | 1.73B | $194.37B | $6.28B | $14.59B | $202.67B |
| 2023-12-31 | $110.07 | 1.73B | $190.87B | $6.9B | $15.87B | $199.85B |
| 2023-09-30 | $96.85 | 1.74B | $168.39B | $6.71B | $15.53B | $177.21B |